Head and Neck Cancer

Intratumoral Bacteria Could Be Used to Predict Outcomes of Nasopharyngeal Carcinoma

By

Vicki Moore, PhD

Publish Date July 28, 2022

Patients with higher intratumoral bacterial loads had significantly worse disease-free survival, distant metastasis-free survival, and overall survival.

More Thyroid Cancers ID’d in Patients With No Symptoms

Publish Date July 25, 2022

Forty-six percent of patients who underwent thyroid-directed surgery had cancer; of these, 51 percent were asymptomatic.

HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity

Publish Date July 21, 2022

Cancer-specific mortality for HPV-related oropharyngeal cancer higher among non-Hispanic Black and Hispanic men than White men.

Induction Chemo Plus CRT More Effective Than CRT Alone in Nasopharyngeal Carcinoma

By

Leah Lawrence

Publish Date July 1, 2022

Induction chemotherapy was associated with improvements in disease-free, failure-free, relapse-free, and progression-free survival.

Acupuncture Improves Symptoms of Radiation-Induced Xerostomia in Head and Neck Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date June 24, 2022

Acupuncture was associated with improvements in symptoms and quality of life.

Rivoceranib Appears Active in Recurrent, Metastatic Adenoid Cystic Carcinoma

By

Leah Lawrence

Publish Date June 22, 2022

Rivoceranib produced responses whether or not patients had received prior treatment with a VEGFR TKI.

Smoking Behaviors Often Continued After Treatment for Head and Neck Squamous Cell Carcinoma

By

Vicki Moore, PhD

Publish Date May 31, 2022

A prospective analysis sought to determine patients’ smoking status after treatment for head and neck squamous cell carcinoma, compared with prior to diagnosis.

Significant Financial Burden Associated With Thyroid Cancer Treatment, Survivorship

By

Jennifer Larson

Publish Date May 18, 2022

An analysis of studies in the literature sought to determine the financial burden patients with thyroid cancer incur from diagnosis, treatment, and surveillance.

Proton Beam Therapy Increasingly Used to Treat Cancers, Even When Evidence of Effectiveness Is Lacking

By

John Schieszer, MA

Publish Date May 11, 2022

The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.

High Neutrophil-Lymphocyte Ratio Linked to Worse Survival in Head and Neck Cancer

By

Sucharita Mistry, PhD

Publish Date May 4, 2022

A high neutrophil-lymphocyte ratio appears to be an independent predictor of outcomes for some patients with head and neck cancer.